ABEONA THERAPEUTICS INC. Stock Issued During Period, Shares, New Issues
ABEONA THERAPEUTICS INC. (ABEO) reported Stock Issued During Period, Shares, New Issues of 1.79 million shares for the 0-month period ending 2021-12-21, per its 10-Q filed 2026-08-13.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesNewIssues · last filed 2026-08-13
- 2021-12-21: Stock Issued During Period, Shares, New Issues 0 month 1.79M shares.
- 2017-10-19: Stock Issued During Period, Shares, New Issues 1 month 5.75M shares.
- 2015-07-31: Stock Issued During Period, Shares, New Issues 2.83M shares.
- 2014-12-24: Stock Issued During Period, Shares, New Issues 3.50M shares.
| Period end | Stock Issued During Period, Shares, New Issues 0 month | Stock Issued During Period, Shares, New Issues | Stock Issued During Period, Shares, New Issues 1 month |
|---|---|---|---|
| 2021-12-21 | 1.79M shares 10-Q · filed 2026-08-13 | ||
| 2017-10-19 | 5.75M shares 10-K · filed 2019-03-18 | ||
| 2015-07-31 | 2.83M shares 10-K · filed 2016-03-30 | ||
| 2014-12-24 | 3.50M shares 10-K · filed 2017-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |